FDA Inspection 1233201 — Novo Nordisk Pharmaceutical Industries LP
The FDA completed an inspection of Novo Nordisk Pharmaceutical Industries LP on Dec 20, 2023 in Durham, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Durham, NC (United States)